A Study of GWP42004 as Add on to Metformin in the Treatment of Participants With Type 2 Diabetes
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
A study to compare the change in glycaemic control in participants with Type 2 diabetes when
treated with GWP42004 or placebo as add-on therapy to metformin over a period of 12 weeks.
The safety and tolerability of GWP42004 compared with placebo will also be assessed.